
Congress trades
Masimo Corporation (MASI)
NASDAQ · Healthcare · 11 congress trades · last filed 1 year ago
About Masimo Corporation
from the company's filings and listing, as of Oct 24, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- Catherine Szymanlast on record
- Employees
- 7,500
- Listed since
- Aug 8, 2007
- Market value
- $9.4Blast quoted Jun 12, 2026
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -
- Dividend yield
- -
Earnings
6 reported quarters| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q1 FY2026reported May 5, 2026 | $1.43 | $1.41 | $399.5M | $398.7M | EPS in lineRevenue in line |
| Q4 FY2025reported Feb 26, 2026 | $0.18 | $1.48 | $412.5M | $408.0M | EPS missRevenue in line |
| Q3 FY2025reported Nov 4, 2025 | $1.32 | $1.19 | $371.5M | $407.6M | EPS beatRevenue miss |
| Q2 FY2025reported Aug 5, 2025 | $1.33 | $1.23 | $370.9M | $369.0M | EPS beatRevenue in line |
| Q1 FY2025reported May 6, 2025 | $1.36 | $1.24 | $372.0M | $367.8M | EPS beatRevenue in line |
| Q4 FY2024reported Feb 25, 2025 | $1.80 | $1.42 | $600.7M | $593.3M | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2024 · proxy filed Mar 26, 2025| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Bilal MuhsinChief Operating Officer | $655K | $5.9M | $1.6M | $8.2M |
| Micah YoungExecutive Vice President and Chief Financial Officer | $628K | $5.9M | $1.6M | $8.1M |
| Tom McClenahanExecutive Vice President, General Counsel and Corporate Secretary | $524K | $5.9M | $723K | $7.2M |
| Blair TripodiChief Operating Officer, Consumer Division | $574K | $5.4M | $851K | $6.9M |
The summary compensation table from the proxy statement for fiscal 2024, with titles as filed then. 2 executives who have since left the company are named in that filing and not shown here. Read the filing
Congress trades in MASI
11 disclosures of 11 on record · median 19d of the 45 allowedSince the trade: the stock's move from the trade date to the last close under this ticker (Jun 12, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Kevin HernJoint | Stock | Sale | $15,001 - $50,000 | +27.3%After the saleS&P 500 +11.1% · +16.2 pts vs S&P 500 | Sep 26, 2025 | Oct 16, 2025 | 20d |
| Kevin HernJoint | Stock | Sale | $50,001 - $100,000 | +29.7%After the saleS&P 500 +93.2% · -63.5 pts vs S&P 500 | Dec 19, 2022 | Jan 13, 2023 | 25d |
| Tommy TubervilleJoint | Stock | Sale (Full) | $1,001 - $15,000 | +23.3%After the saleS&P 500 +95.5% · -72.3 pts vs S&P 500 | Oct 5, 2022 | Nov 10, 2022 | 36d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +26.5%S&P 500 +85.8% · -59.3 pts vs S&P 500 | May 23, 2022 | Jun 10, 2022 | 18d |
| Tommy TubervilleJoint | Stock | Purchase | $1,001 - $15,000 | +15.8%S&P 500 +60.7% · -44.9 pts vs S&P 500 | Mar 30, 2022 | Apr 8, 2022 | 9d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +18.1%After the saleS&P 500 +68.6% · -50.5 pts vs S&P 500 | Feb 17, 2022 | Mar 8, 2022 | 19d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -17.4%S&P 500 +68.3% · -85.7 pts vs S&P 500 | Jan 21, 2022 | Feb 8, 2022 | 18d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -37.4%S&P 500 +57.2% · -94.6 pts vs S&P 500 | Nov 8, 2021 | Dec 7, 2021 | 29d |
| Kevin HernJoint | Stock | Purchase | $15,001 - $50,000 | -26.3%S&P 500 +72.2% · -98.5 pts vs S&P 500 | Jun 25, 2021 | Jul 14, 2021 | 19d |
| Kevin HernJoint | Stock | Purchase | $100,001 - $250,000 | -26.3%S&P 500 +72.2% · -98.5 pts vs S&P 500 | Jun 25, 2021 | Jul 14, 2021 | 19d |
| Thom TillisJoint | Stock | Sale (Full) | $1,001 - $15,000 | +557.2%After the saleS&P 500 +252.3% · +305.0 pts vs S&P 500 | Feb 13, 2015 | Feb 26, 2015 | 13d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in MASI, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded MASI?
Kevin Hern, Tommy Tuberville, Ro Khanna and Thom Tillis disclosed MASI transactions in the filings shown here.
How quickly are MASI trades disclosed?
Congressional disclosures took a median of 19 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.
